Internal Medicine, Allina Health, Minneapolis, Minnesota, USA.
Internal Medicine, Allina Health, Minneapolis, Minnesota, USA
BMJ Open. 2022 Feb 23;12(2):e050879. doi: 10.1136/bmjopen-2021-050879.
To determine outcomes in hospitalised patients with sepsis and reported penicillin allergy (PcnA).
Observational retrospective cohort study using data from electronic health records.
A large single health system with 11 hospitals of small, medium and large sizes including a 630-bed tertiary care teaching hospital.
Patients (n=5238) ≥18 years of age, hospitalised with sepsis, severe sepsis or septic shock between 1 January 2016 and 31 December 2018, received antibacterial agents, and had documented PcnA status. Patients <18 years of age at admission were excluded.
Primary outcomes evaluated were inpatient mortality and 30-day mortality posthospital discharge. Secondary outcomes were hospital length of stay, 30-day readmissions, duration of antibiotic use, rate of infection and total cost of care.
There was no difference in outcomes including inpatient or 30-day mortality, hospital length of stay, in-hospital antibiotic duration, infection, total cost of care and 30-day readmission rate between patients labelled with a PcnA vs patients who did not report PcnA (non-PcnA).
In this retrospective single health system study, there was no difference in key outcomes including inpatient or 30-day mortality in patients admitted with sepsis and reported PcnA compared with patients who reported no PcnA.
确定报告有青霉素过敏(PcnA)的住院脓毒症患者的结局。
使用电子病历数据进行回顾性观察性队列研究。
一个拥有 11 家大小不一的医院的大型单一医疗系统,包括一家拥有 630 张床位的三级保健教学医院。
18 岁以上,2016 年 1 月 1 日至 2018 年 12 月 31 日期间因脓毒症、严重脓毒症或脓毒性休克住院,接受抗菌药物治疗,且有记录的青霉素过敏状态的患者。入院时年龄<18 岁的患者被排除在外。
评估的主要结局为住院期间死亡率和出院后 30 天死亡率。次要结局为住院时间、30 天再入院率、抗生素使用时间、感染率和总治疗费用。
在住院或 30 天死亡率、住院时间、住院期间抗生素使用时间、感染率、总治疗费用和 30 天再入院率等结局方面,标记有 PcnA 的患者与未报告 PcnA 的患者(非 PcnA)之间无差异。
在这项回顾性单一医疗系统研究中,与未报告青霉素过敏的患者相比,报告有青霉素过敏的住院脓毒症患者的关键结局,包括住院或 30 天死亡率方面无差异。